Effect of chaturjat tail Nasya in cold

A CLINICAL STUDY TO EVALUATE THE EFFICACY OF CHATURJAT TAIL NASYA PRATIMARSH IN VATAJ PRATISHAYAY WITH REFERENCE TO ALLERGIC RHINITIS

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/01/030343

Enrollment

Registered

2021-01-08

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J00- Acute nasopharyngitis [common cold]

Interventions

Intervention1: Chaturjat tail Nasya in vataj Pratishyay (pratimarsha): Chaturjat tail include Twak(cinnamommum zelynica),Ela(Elatteria cordonomum),Tejpatta (cinnamommum Tamala),Nagkeshar (Museaferra)

Eligibility

Inclusion criteria

Inclusion criteria: Patient having symptoms of Vataj Pratishyay. • Those who give assignment or consent, as per requirement.

Exclusion criteria

Exclusion criteria: Patients K/C/O hypertension, Diabetic mellitus, heart disease and bronchial asthma. Patients presenting with complications of pratishyay like nasal polyps, tumour of nose, DNS, old fracture of nose. If patients is suspected of COVID â?? 19 infection after scanning with respect to clinical signs & symptoms and history of patients, than he/she will be referred through proper channel for further treatment. She/he will not be included in trial.

Design outcomes

Primary

Measure	Time frame
mtoms like nasasrava, nasanaha, nasaraktata, kshavathu, shiroshoola will be assessed after nasyaTimepoint: 7 days	—

Secondary

Measure	Time frame
lief from symptoms like nasasrava, nasanaha, nasaraktata, kshavathu, shiroshoola.Timepoint: 7 days	—

Countries

India

Contacts

Public ContactDr Meenakshi Bhati

Parul institute of Ayurveda

meenakshibhati146@gmail.com7791998930

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026